Life Sciences Partners — Full Portfolio

5 tracked investments · listed companies and verified rows first

BiotechEast Providence, US

Manny Avila(Executive Officer, Director)in Dirk Kuyper(Executive Officer, Director)inRobert Rabiner(Executive Officer)

BoardDaniel Omstead(Director)Fouad Azzam(Director)inRajeev Dadoo(Director)

Co-investorsPappas Capital SR One Capital Management

Imcheckimchecktherapeutics.com inSep 2020acquired by Clementia

ImCheck Therapeutics develops next-generation immunotherapeutic antibodies targeting the butyrophilin (BTN) and BTN-like (BTNL) superfamily of checkpoint molecules for immune system modulation.

BiotechHealthtech

Co-investorsAgent Capital Andera Partners Kurma Partners Pfizer Venture Investments Pureos Bioventures Alexandria +4 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

ActoGeniXHarvest AutomationProsensa

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.